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Background: It has been hypothesized that fatty acids derived from a diet high in saturated fat may negatively
affect endothelial function more significantly than a diet high in unsaturated fat; nevertheless, the effects of the
long-term ingestion of monounsaturated fatty acids on endothelial function have been poorly studied.
Methods: To examine the chronic effects of monounsaturated (e.g., extra virgin olive oil (EVOO)) or saturated (e.g.,
margarine (M)) fatty acid-rich diets on the development of insulin resistance and endothelial dysfunction in rats,
three groups of rats were fed control, high-EVOO or high-M diets for 20 weeks. Body weight, energy consumption,
insulin resistance, lipid peroxidation and in vitro vascular reactivity with and without metformin were assessed
during the study period.
Results: Both high-fat diets produced obesity and insulin resistance. EVOO-fed rats showed smaller increases in
total cholesterol and arterial lipid peroxidation when compared with M-fed rats. Vascular reactivity to phenylephrine
and sodium nitroprusside was not modified, but the vasodilating effect of carbachol was especially reduced in the
M-fed rats compared with the EVOO-fed or control groups. Metformin addition to the incubation media decreased
the vascular response to phenylephrine; decrease that was lower in rats fed with both high fat diets, and increased
the carbachol and nitroprusside effects, but the metformin-enhanced response to carbachol was lower in the M
group.
Conclusions: Our results suggest that feeding rats with high quantities of EVOO, despite producing obesity and
insulin resistance, produces low levels of circulating cholesterol and arterial lipoperoxidation compared to M fed
rats and shows a preserved endothelial response to carbachol, effect that is significantly enhanced by metformin
only in rats fed with control and EVOO diets.
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During the last few decades, sedentary lifestyles and tran-
sient changes in consumption patterns, including a sharp
increase in fat consumption from vegetable oils and
animal-based food sources, have led to drastic increases
in the prevalence of overweight and obese individuals
in many developed and developing countries [1]. The* Correspondence: quevedocorona@hotmail.com
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reproduction in any medium, provided the orimportance of fat consumption in the development of in-
sulin resistance, type 2 diabetes mellitus and cardiovascu-
lar disease has also been shown [2,3], but differences in
weight gain and predisposition to cardiovascular disease in
some populations suggest that dietary fat composition
plays an important role in determining the development
of these chronic diseases [4,5]. Diets rich in saturated
fatty acids (SAFA) have been linked to endothelial dys-
function, which contributes to macrovascular alterations.
On the other hand, the Mediterranean diet, which is
mainly characterized by abundant vegetables, fruits,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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main dietary fat, low fat dairy and animal products which
guarantees the low consumption of saturated fats, has
been recognized for its positive effects on cardiovascular
health [6,7] and its protective effect against the develop-
ment of obesity and diabetes [8-10]. In the Mediterranean
region, total daily lipid intake may contribute with the
40% of total energy intake in Greece, or 30% in Italy,
hence, olive oil plays a central role in this diet [11]. Many
studies have attributed some of the beneficial effects of the
Mediterranean diet to olive oil phenolic compounds with
high antioxidant capacity, e.g., hydroxytyrosol, tyrosol,
oleuropein aglycon and its derivatives, which are naturally
found in extra virgin olive oil and to the high proportion
of monounsaturated fatty acids (MUFA), namely oleic acid
[12-14]. EVOO polyphenols have been reported having
strong anti-inflammatory properties [14], decrease oxi-
dized low-density lipoproteins, decrease blood pressure
and improve endothelial function in humans [15] and pre-
vent oxidative DNA damage [16]. Interestingly, in a recent
study, an extra virgin olive oil, rich in oleic acid, has been
shown having antioxidant properties and an improved
adaptive response of the body in rats submitted to ex-
haustive exercise [17].
It has also been reported that MUFA consumption
leads to a decrease in low-density lipoprotein (LDL)
cholesterol [18], while saturated fat intake increases LDL
levels [19,20]. Concurrently, other studies have suggested
that unsaturated fat increases LDL cholesterol in a man-
ner similar to what has been observed with saturated fat,
but saturated fat, especially trans fats, simultaneously de-
creases high-density lipoprotein (HDL) cholesterol levels
and increase the deposition of cholesterol into cellular
plasma membranes in vascular tissues, leading to the
development of atherosclerosis over time [21,22]. The
general consensus is that the dietary intake of SAFA in-
creases cardiovascular risk but that MUFA and polyun-
saturated fatty acids (PUFA) intake decreases risk [23].
Contrarily, it has been shown that increased circulating
concentrations of cholesterol and free fatty acids reduce
the endothelial bioavailability of nitric oxide (NO) due
to both the increased generation of superoxide and a re-
duction in endothelial NO synthase activity [24,25]. Re-
active oxygen species can react with the cell membrane
PUFAs, causing lipid peroxidation and thus altering
the vasodilatory function of the endothelium [26]. Fur-
thermore, adipose tissue secretes free fatty acids and
cytokines, a process that is intimately involved in the de-
velopment of insulin resistance and contributes to a
proinflammatory state which, overall, puts a patient at
an increased cardiovascular risk [27-29]. Many studies
have shown that vascular complications are a major
cause of mortality in diabetic patients [30] and that the
endothelium plays a critical role in controlling vasculartone and blood flow by synthesizing mediators of vaso-
dilation and vasoconstriction.
Impaired endothelium-dependent vasodilation in obesity-
associated insulin resistance [31] and diabetes [32] is
characterized by a diminished NO production and the de-
velopment of a pro-inflammatory vascular phenotype that
promotes atherosclerosis and adverse cardiovascular events.
Previous studies of rats fed with high-fat diets enriched
with olive oil for 4 weeks showed that the rats achieved low
body weights [33] and retained a normal insulin sensitivity
[34]. In contrast, Buettner et al. [35] found that feeding rats
a diet high in EVOO over a long period of time produces
obesity and insulin resistance, similar to what is seen in
animals fed a lard-based diet. These findings suggest that
obesity and the deleterious effects on vascular integrity of
ingesting high quantities of fats may only occur with
chronic ingestion. Most of the recent studies on beneficial
effects of EVOO were conducted with either well balanced
or hypocaloric diets, but there are scant and contradictory
data about the effects due to a high EVOO ingestion, there-
fore the aim of this study was to determine if the long-term
consumption of a hypercaloric diet high in monounsatu-
rated fatty acids such as the extra virgin olive oil produces
obesity, insulin resistance and endothelial dysfunction in
rats as well as compare these effects with those of a
hypercaloric diet high in saturated fat.
Methods
Animals and diets
Twenty seven male Wistar rats, obtained from the Univer-
sity of Hidalgo and initially weighing between 120–150 g
(5–6 wk old), were housed in individual cages in a
temperature-regulated room (22°C ± 2°C) with 12-hour
dark–light cycles (lights on from 7:00 AM to 7:00 PM).
After one week of acclimatization, nine rats were assigned
to each diet group (control, EVOO, M), and the specialized
feedings were initiated. The animals had free access to their
respective diets. The control animals were fed a commer-
cial diet (Rodent Laboratory Diet 5001 PMI, Richmond,
IN), with a total energy content of 13.68 kJ/g. The
remaining animals received a high-fat diet (25% extra virgin
olive oil or margarine was added to the standard diet). Both
high-fat diets had an energy content of 19.68 kJ/g (54.2% of
total energy derived from fat). We used an Italian EVOO
containing 474.2 mg/kg polyphenols that was purchased in
a local market. The total phenol content was deter-
mined colorimetrically at 725 nm following the Folin &
Ciocalteau method in the extracts in triplicate as previ-
ously described [36] and expressed as milligrams of
galic acid equivalents per kilogram of oil. The EVOO
comprised 15.44% saturated fat, 74.47% unsaturated fat
and 10.07% polyunsaturated fat; while, the M com-
prised 57.14% saturated fat, 25.71% unsaturated fat and
17.14% polyunsaturated. The macronutrient compositions
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per animal was measured daily, and body weights were
determined for each animal once a week over the
20-week period. All of the experimental procedures were
conducted according to the recommendations of the
Guide for the Care and Use of Laboratory Animals of the
Mexican Council for Animal Care (NOM-062-ZOO-1999)
and were approved by the National School of Biological
Sciences Ethics and Biosecurity Committee.
Reagents
(R)-(−)-phenylephrine hydrochloride, isoproterenol hydro-
chloride, sodium nitroprusside and metformin (1.1 dime-
thylbiguanide hydrochloride) were all purchased from
Sigma and Sigma-Aldrich, and carbachol was purchased
from Research Biochemicals International. Rat/mouse in-
sulin ELISA kits were purchased from Millipore (Linco
Research Inc., St. Charles, MO, USA).
Blood and serum measurements
After twenty weeks of experimental feeding, blood sam-
ples were obtained from the tips of the rats’ tails at
8:00 AM, following an overnight 12-hour fast. The glucose
levels were determined in whole blood with a glucose
meter (Optium medisense, Abbott Laboratories, Oxford,
United Kingdom). The samples (0.5 mL) were collected
at the conclusion of the experiment to determine the
total cholesterol, HDL-cholesterol and triglyceride (TG)
levels using specific enzymatic-colorimetric kits (Randox,
Crumlin, UK). The samples were centrifuged at 3500 rpm
for 15 min at 4°C. Plasma LDL- cholesterol levels were cal-
culated using the formula of Friedeward et al. [37].
Blood glucose and serum insulin levels during the
intraperitoneal glucose tolerance test
An intraperitoneal (IP) glucose tolerance test (GTT) was






High-fat diet High-fat diet
Protein 23.0 17.25 17.25
Carbohydrate 48.7 36.53 36.53
Total fat 4.5 28.37 28.37
Fat from chow 4.5 3.37 3.37
EVOO - 25.0 -
Margarine - - 25.0
Fiber 6.0 4.5 4.5
Minerals 7.0 5.3 5.3
Vitamins 1.0 0.75 0.75
Moisture 10.0 7.5 7.5
EVOO extra virgin olive oil.Basal blood samples were obtained from the tip of the
tail, and a 35% glucose solution was intraperitoneally
injected (3 g/kg body weight). At 15, 30, 60, 120 and
180 minutes post-glucose administration, blood glucose
levels were determined [38]. Fasting blood samples
(0.25 mL) were obtained in basal conditions and were
centrifuged at 3500 rpm for 15 minutes at 4°C. The
resulting serum was kept frozen at −70°C until insulin
levels were determined [39]. Insulin resistance was eval-
uated using the homeostasis model assessment of insulin
resistance (HOMA-IR), which is calculated as the prod-
uct of the fasting serum insulin (μU/mL) and the fasting
blood glucose (mg/dL) divided by 2430 [40].
Intraabdominal fat pad weights
At week 20, the rats were anesthetized with diethyl ether
and euthanized by decapitation. The thoracic region was
immediately dissected, and a segment of aorta, between
the arch and the diaphragm, was removed for use in the
study of endothelial function. The abdominal region was
then dissected, and the intraabdominal fat deposits
were excised and weighed. Accurately weighed samples
from the aorta, liver and heart were also taken for the
lipoperoxidation assay.
Lipid peroxidation assay
Lipid peroxidation in the artery, heart and liver was
assessed by measuring the malondialdehyde (MDA) con-
tent, as described by Buege and Aust [41], but with
minor modifications. Briefly, 50 mg of tissue was ho-
mogenized in 0.5 mL of cold phosphate buffer (pH 7.4),
followed immediately with the addition of 1 mL of a re-
agent containing trichloroacetic acid, thiobarbituric acid
and HCl [15% (w/v), 0.375% (w/v) and 0.25 N, respect-
ively] to the homogenate. This solution was then heated
for 60 min in a boiling water bath. After cooling, the
flocculent precipitate was removed by centrifugation at
1000 g for 10 min. A spectrophotometer was used to de-
termine the absorbance at 532 nm. A sample containing
reagent, only, was used as a blank. The MDA content
was calculated using an extinction coefficient of 1.56 ×
10-5 M-1 cm-1. The protein content was determined
using the Coomassie blue method [42], with bovine
serum albumin as the standard.
Measurement of isometric force
The segment of thoracic aorta was placed in oxygenated,
modified Krebs-Hanseleit solution (KHS) (NaCl, KCl,
NaHCO3, CaCl2, NaHPO4, MgSO4, dextrose and EDTA).
The thoracic aorta was cleaned of loosely adhering fat
and connective tissue. It was cut into 3-mm-wide rings
and then placed in an oxygenated (95% O2, 5% CO2)
bath with 10 ml of KHS, with one end of the specimen
connected to a tissue holder and the other to a
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Barbara California, Model MP100). First, the aortic
ring was equilibrated for 45 min under a resting tension
of 2.0 g. After equilibration, the aortic rings were
precontracted with phenylephrine (1 × 10-6 M), and after
reaching a stable plateau phase were exposed to carba-
chol (1 × 10-6 M) to verify the functionality of endothe-
lium. Contraction was evoked again with phenylephrine
(1 × 10-6 M), then cumulative concentration-response
curves to sodium nitroprusside or carbachol were deter-
mined from 1 × 10-8 to 1 × 10-4 M for the relaxation
studies. In another set of experiments, cumulative
concentration-response curves to phenylephrine (1 × 10-8
to 1 × 10-4 M) were generated.
Metformin has been widely used to increase glucose
and lipid metabolism in patients and rodent models of
type 2 diabetes mellitus and insulin resistance to im-
prove glycemic control and lower blood pressure. How-
ever, the insulin resistance mechanisms to increase
incidence of vascular disease are not completely under-
stood [43]. Additionally, as metformin has been reported
to relax isolated arterial preparations through a nitric
oxide dependent mechanism [43], we hypothesized
that addition of metformin to the incubation media
should improve the response to vascular active sub-
stances, showing differential effects in relation to fat
diet composition. Thus, after performing the previous
experiments, the aortic ring segments were washed suf-
ficiently to recover their basal contraction (2.0 g) and
were incubated in metformin (10-4 M) for 40 min, fi-
nally, the first experiment was repeated using the same
incubation medium.Statistical analyses
The results are presented as the means ± SEM, and one-
way ANOVA, two-way RM-ANOVA or three-way RM-
ANOVA analyses were used to compare the mean values
among the different groups, followed by further analysis
with the Student-Newman–Keuls’ post hoc test. In all
cases, a P value of 0.05 or less (two-tailed) was consid-
ered statistically significant.Results
Food consumption, energy intake and body weight
The rats fed with extra virgin olive oil and margarine di-
ets ingested significantly less food than the control diet
rats P < 0.05 (data not shown); however, the overall en-
ergy intake and body weights were significantly higher in
both of the high-fat diet group rats (EVOO and M) than
in the control group (P < 0.05; Figures 1A and 1B) at the
conclusion of the 20 weeks of dietary treatment. No sig-
nificant differences in these variables between the two
high-fat diets were found.Glycemia and glucose tolerance
At week 20 of dietary treatment, an IP injection of a glu-
cose solution (3 g/kg) produced a significant increase in
glycemia after 15 minutes in all animals. At 30 minutes,
blood glucose levels decreased only in the control rats
and were significantly lower in these rats compared with
the HF-fed rats. At 180 minutes, the control diet group
had recovered to their baseline blood glucose levels, but
the HF-diet groups had not (Figure 2A). The area under
glucose curve was significantly greater in the HF-diet
groups than in the control group (Figure 2B). However,
the corresponding insulin levels under fasting conditions
were not different between the groups. The HOMA-IR
analysis revealed significant differences in insulin resist-
ance between the HF-diet groups and the control group
(Table 2).
Serum total cholesterol, lipoprotein cholesterol (HDL and
LDL) and triglycerides (TG)
Total cholesterol, HDL, LDL and TG plasma concentra-
tions after 20 weeks of dietary treatment varied between
the experimental groups. M-fed rats showed higher total
and LDL-cholesterol plasma levels than those found in
the control or EVOO-fed rats (P < 0.05), but HDL and
TG levels did not differ significantly between the dietary
groups (Table 3).
Intraabdominal fat pad weights
The combined weight of the retroperitoneal, epididymal
and mesenteric fat pads, expressed as a percentage of
body weight, was greater for the HF-diets rats than for
the control rats (Table 3).
Lipid peroxidation
Malondialdehyde levels in the thoracic aortas, hearts
and livers of the M-diet group were significantly higher
than the levels found in either the control or EVOO
group (P < 0.05; Table 4).
In vitro aortic response to phenylephrine in the absence
and presence of metformin
In generating the concentration-response curves for
phenylephrine, there were no significant differences
detected between the diet groups (P > 0.05) (Figure 3A).
However, incubation of the aortic rings with metformin
(10-4 M) significantly reduced the vasoconstrictor re-
sponse (P < 0.05) to phenylephrine, but the effect was
lower in both high-fat diet groups than in the control
group (Figure 3B).
Relaxation response to carbachol or sodium nitroprusside
in the absence or presence of metformin
The addition of phenylephrine (1 × 10-6 M) to the incu-
bating medium induced a maximum contraction that
Figure 1 Changes in body weight and energy intake. Energy intake (A) and body weight (B) of rats fed with control or high-fat olive oil or
margarine diets for 20 weeks. * P < 0.05, significant difference compared with the control group by 2-way RM ANOVA (n = 9 per group).
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response curve for sodium nitroprusside was deter-
mined for each group (1 × 10-8 to 1 × 10-4 M), both in
the presence and absence of metformin. The relaxing
effect of carbachol was significantly lower in the M-fed
rats compared with the EVOO-fed or control groups
(Figure 3C). Metformin increased the relaxation pro-
duced by carbachol in all of the dietary groups, but
the metformin effect was less pronounced in the
M-fed group (Figure 3D). There were no significant
differences in the relaxation response to sodium
nitroprusside of the experimental groups, either in the
presence or absence of metformin (P > 0.05), but there
was a significant difference within each group in their
responses to sodium nitroprusside before and after
the addition of metformin to the incubation medium
(Figure 3E and 3F).Figure 2 Effect of the HF-diets on blood glucose levels. Glycemia (A) a
following an IP injection of 3 g/kg of glucose solution in rats fed a control
(for A) and one-way ANOVA (for B). *P < 0.05, significant difference compaDiscussion
The high consumption of energy-dense vegetable fat and
physical inactivity are considered major causes of obes-
ity. Many studies have demonstrated that high-fat diets
have contributed to the increased prevalence of insulin
resistance [44-46] and to the eventual development of
diabetes in genetically susceptible individuals and popu-
lations [31,47,48]. This study shows that two different
vegetable fat have different metabolic and vascular ef-
fects in rats subjected to high-fat diets of isoenergetic
value. Ingesting high levels of extra virgin olive oil pro-
duces obesity and insulin resistance in study rats, which
is comparable to what is observed in margarine-fed rats,
but only the margarine-heavy diet produced hyperchol-
esterolemia and significant endothelial dysfunction. In
agreement with other reports [4,49,50] the rats fed HF
diets ingested more energy and gained more weight thannd the area under the glucose curve (B) after 12 hours of fasting
or a high-fat diet (EVOO or M) for 20 weeks by 2-way RM ANOVA
red with the control group. (n = 9 per group).
Table 2 Fasting blood glucose, plasma insulin levels and
HOMA-IR after 20 weeks of dietary treatment
Control EVOO M
Glucose (mg/dL) 92.5 ± 3.2 97.1 ± 4.2 113.1 ± 8.3*,&
Insulin (μU/mL) 22.51 ± 0.11 22.76 ± 0.52 22.93 ± 0.28
HOMA-IR 0.81 ± 0.03 1.07 ± 0.08* 1.14 ± 0.11*
Values are expressed as the means ± SEM (n = 9 per group). *P < 0.05,
significant difference compared with the control group; & P <0.05, significant
difference compared with the EVOO group by one-way ANOVA.
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ies support an anti-obesogenic effect of EVOO [33,51],
but other longer-term studies report weight gain with
sustained EVOO intake [35]. This discrepancy could be
partly explained by the duration of dietary treatment
(4 weeks vs. 12 weeks) or the quantity of EVOO admin-
istered [34]. Indeed, our results support that obesity de-
pends on the quantity of fat ingested, its composition
and the duration of dietary treatment. This is because
high-fat feeds in rats require at least 4 weeks of treat-
ment to produce a significant increase in body weight,
and both monounsaturated and saturated fatty acids
favor adiposity. In recent years, the adherence to the
Mediterranean diet has been associated with lower risk
for cardiovascular disease [6]. This diet is characterized
by the high consumption of fruits, vegetables, cereals,
fish and virgin olive oil. This Mediterranean dietary pat-
tern has a low energy density and a high fiber content
that contributes to satiation which may explain the
lower body weight, abdominal fat deposition and fasting
blood glucose reported with the adherence to this diet
[7,52]. In contrast, our results show that feeding rats
with the hypercaloric and unbalanced high-fat diets
based on EVOO or M, produce an increase in energy in-
gestion that may lead to the accumulation of visceral fat,
which in turn is linked to the progression of insulin re-
sistance and impaired glucose tolerance [35,53,54]. In
our rats, 3 hrs after the administration of a glucose load,
blood glucose levels had decreased to their basal levels
in the control group, only. The lower capacity of rats
maintained on HF diets (EVOO or M) to return to their
basal levels of glucose is indicated by the greater areasTable 3 Serum total cholesterol, HDL, LDL and TG
concentrations, and intraabdominal fat
Control EVOO M
Total Cholesterol (mg/dL) 71.54 ± 4.6 72.31 ± 2.6 84.0 ± 5.0*
TG (mg/dL) 58.46 ± 5.3 67.32 ± 3.5 65.54 ± 4.4
HDL cholesterol (mg/dL) 19.72 ± 2.3 21.6 ± 2.3 18.9 ± 2.3
LDL cholesterol (mg/dL) 40.0 ± 5.2 37.3 ± 3.4 52.0 ± 5.0*
Intraabdominal fat
(g/100 g body weight)
5.18 ± 0.57 9.06 ± 0.44* 8.71 ± 0.63*
* P < 0.05, significant difference compared with the control group by one-way
ANOVA (n = 9 per group). Values are expressed as the means ± SEM.under their glucose curves (Figure 2). Moreover, the
HOMA-IR analysis, which indicates insulin resistance
under fasting conditions, revealed significant differences
between the HF-diet groups and the control group, with
the HF-fed rats showed signs of insulin resistance. Con-
sistent with this result, it has already been shown that
HF diets contribute to glucose intolerance and the sub-
sequent development of insulin hypersecretion after a
glucose load [50,55] because the body attempts to keep
glucose at normal physiological levels. Several studies
have reported that visceral adipocytes are less responsive
than subcutaneous fat cells to the antilipolytic effect of
insulin [56,57] and that exposure of the liver to high
concentrations of free fatty acids can induce changes in
insulin signaling that promote hepatic insulin resistance
[58]. In summary, the metabolic impact of high oleic
acid intake on glucose and lipid metabolism is not con-
clusive in humans, whereas it clearly leads to obesity
and insulin resistance in rats [35]. Although, dietary fat
composition plays an important role in the prevention of
cardiovascular disease (CVD) and metabolic syndrome
[59,60], it has been suggested that the total intake of fat
(SAFA, MUFA and PUFA), regardless of the quality of
the fat, can increase the risk of CVD [23]. In this study,
EVOO and M diets have shown to exert different effects
on the vasomotor response of endothelial tissue, show-
ing signs of altered function in the margarine-fed group,
only. Extra virgin olive oil is rich in unsaturated fatty
acids, mainly oleic acid, and phenolic compounds [12],
which contribute to its cardioprotective effects [14]. In
contrast to EVOO, margarine has a high saturated fatty
acid content, which is produced industrially via the hy-
drogenation of unsaturated oils [61]. Many studies have
shown that consumption of these fats contributes to an
increased cardiovascular risk [23]. As our results show,
lipid peroxidation was elevated only in the rats that were
maintained on a high-M diet. These results suggest
that the consumption of a high-M diet, over a period of
20 weeks, leads to increased levels of oxidative stress,
hypercholesterolemia and insulin resistance which in
turn lead to alterations in tissue function, including
endothelial vasomotor response. These findings are con-
sistent with many studies that have shown that the
antioxidant properties of EVOO are mainly due to its
high content of polyphenolic compounds [12], which are
strong antioxidants and radical scavengers [62,63]. In
contrast, saturated fatty acids increase oxidative stress
and thus modify the lipid composition of cell mem-
branes [64,65]. Consistent with these studies, our results
indicate that the serum lipid profiles of rats maintained
on the M diet reflected higher levels of total and
LDL cholesterol compared with the rats fed high-EVOO
or control diets. It is well documented that hypercholes-
terolemia is associated with a higher incidence of
Table 4 Malondialdehyde levels in the aorta, heart and liver
Tissues Control EVOO M
Arterial MDA (mM/mg Protein) 15.76 ± 1.83 22.94 ± 4.58 50.46 ± 5.56*,&
Heart MDA (mM/mg Protein) 3.77 ± 0.34 3.83 ± 0.59 7.13 ± 0.20*,&
Hepatic MDA (mM/mg Protein) 3.09 ± 0.22 3.25 ± 0.34 5.62 ± 0.47*,&
Values are expressed as the means ± SEM (n = 9 per group). MDA malondialdehyde. * P < 0.05, significant difference compared with the control group. & P < 0.05,
significant difference between the EVOO and M groups according to one-way ANOVA.
Figure 3 Effects of the HF-diets on endothelial function. Concentration-response curves for phenylephrine (A) and (B), carbachol (C and D)
or sodium nitroprusside (E and F) before and after metformin addition to the incubation media of thoracic aortic rings obtained from age-matched
control, EVOO and M rats (n = 9 per group). The results show the contraction of the thoracic aortic rings as a percentage of the maximal contraction
induced by phenylephrine (10 -8 to 10-4 M) and the relaxation as a percentage of the effect induced by carbachol (1 × 10-8 to 1 × 10-4 M) or sodium
nitroprusside (1 × 10-8 to 1 × 10-4 M). * P < 0.05 significant difference compared with the control group; & P < 0.05 significant difference compared with
the control and the EVOO groups by 2-way RM ANOVA. Values are the means ± SEM.
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significant difference in the levels of TG, there was an
increasing trend in this parameter in M-fed rats, which
suggests that, even though all of the rats that were fed
high-fat diets (EVOO or M) were obese, the EVOO-high
diet still conferred a lower cardiovascular risk compared
with the M-high diet. Given that obesity has been linked
to insulin resistance and increased inflammation, causing
endothelial dysfunction, EVOO-fed rats should also be
expected to show signs of altered endothelial function.
Carbachol-induced NO production and vasodilation are
conserved in these rats, however, suggesting that the
expected endothelial damage had been prevented. It has
been shown that oleic acid, the major fatty acid constitu-
ent in EVOO and polyphenols, diminishes the oxidation
of olive oil-derived lipoproteins, thus mitigating any po-
tential oxidative damage to endothelial vasomotor func-
tion. These results support the finding that, among
EVOO compounds, polyphenols, mainly hydroxytyrosol
and tyrosol, increase NO production and prevent the
formation of the powerful oxidant peroxynitrite [26].
The concentration-response curve for phenylephrine
showed that the high-fat diets did not modify the endo-
thelium’s vasoconstrictive response to this substance,
nor did they affect the tissue’s vasodilatory response to
sodium nitroprusside. However, the M diet did reduce
the relaxation generated by carbachol, suggesting that
the ingestion of significant amounts of saturated fat af-
fected the endothelium-dependent vasorelaxation re-
sponse in the rats fed the M diet. Hypercholesterolemia
and high levels of lipid peroxidation in the arteries are
likely to be associated with the alteration in vascular re-
sponse because it is well known that inflammation plays
a key role in the onset of atherosclerosis and oxidative
stress and may also contribute to increased endothelial
damage [67]. Earlier studies support the hypothesis that
endothelial dysfunction is associated with a reduction in
the release [68] or availability of NO, the production of
which is downregulated in the presence of reactive oxy-
gen species (ROS), the production of which, in turn, is
generally increased in the obese state [31]. Although
the results of this study showed an increased aortic
lipoperoxidation in M fed rats, and there were signifi-
cant differences in endothelial response to vasorelaxing
substances among HF diets groups, the differences in
endothelial reactivity were lower than was expected
for the high values of lipoperoxidation in M-fed rats,
suggesting that the quantity of fats in the diets (25% w/w)
was very high and duration of the regimen diet (20 weeks)
was too long, producing some common alterations not re-
lated to lipoperoxidation in both HF rat diets. Further-
more, there were no high differences when comparing to
control rats, thus indicating as previously suggested that
the process of maturation and aging in rat lead todegenerative changes at the cellular level including arterial
endothelial cells function [69]. Indeed, a reduction in the
dietary intervention could show higher differences in endo-
thelial function between EVOO and M diets. As our results
show, there was no significant difference in the vasodila-
tory responses to sodium nitroprusside in the arteries from
the experimental groups, which suggests that the limited
vasodilatory response to carbachol (muscarinic agonist)
that was observed in the arteries of the M-fed rats was
due to a lower endothelial production of NO. The
diets did not affect the endothelial response to alpha-
1-adrenergic (phenylephrine) or beta-adrenergic (iso-
proterenol, results not shown) agonists, which may
indicate that the diets had no effect on the adrenergic
vascular response. Furthermore, this study corroborates
previous findings that incubation of the aorta rings from
streptozotocin-induced diabetic rats with metformin en-
hanced the carbachol-induced relaxation and reduced
the phenylephrine-induced contraction, which have been
reported to be endothelium dependent [70], similarly, in
our insulin resistant rats, the addition of metformin to
the incubation media showed a lower reduction of the
phenylephrine-induced contraction in both high fat diet
fed rats compared to control rats, but an even lower re-
sponse to carbachol in M rats, indicating that just high
M diet altered both endothelium dependent relaxing
mechanisms. Metformin vasodilatory effects have been
proposed to be associated with the activation of AMP-
activated protein kinase which increases the activity
of endothelial NO synthase [71]. Additionally, the en-
hanced vasodilator effect of nitroprusside indicates that
metformin also produces relaxation through a mechan-
ism that is independent of endothelial NO production,
possibly via the decreased production of vasoconstricting
prostanoids [72] or decreased intracellular calcium [73],
both of which are factors that could be altered and by
doing so, contributing to lower the endothelial response in
M-fed rats.
Conclusions
In conclusion, we found that the long-term high-fat in-
take lead to obesity and insulin resistance, regardless of
the fat composition (saturated or monounsaturated).
Nevertheless, EVOO did not increase plasma levels of
total cholesterol or LDL cholesterol, nor did it increase
arterial lipid peroxidation, which may contribute to the
preservation of endothelial response to carbachol, effect
that is significantly enhanced by metformin only in rats
fed with control and EVOO diets. Further to this prelim-
inary study, longer-term animal and in vitro studies are
needed to better understand the mechanisms regarding
the ingestion of a diet high in extra virgin olive oil to
produce obesity and insulin resistance but protect endo-
thelial function.
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